Hypercoagulability in sickle cell disease: a curious paradox.
about
Magnesium for treating sickle cell diseaseSickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagyMagnesium for treating sickle cell diseaseP-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease.Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants.Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease.Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.Sickle cell disease and venous thromboembolism.Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to knowErythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulationExperimental and imaging techniques for examining fibrin clot structures in normal and diseased states.Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersEffect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.Increased homocysteine level in Indian sickle cell anemia patients.Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first reportN-acetylcysteine reduces oxidative stress in sickle cell patientsHaematology and neurology.Hypercoagulability in congenital haemolytic anaemiasCentral venous line-related thrombosis in children.Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature reviewHLA class II haplotypes distinctly associated with vaso-occlusion in children with sickle cell disease.Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivityPatent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature.Stroke in sickle cell anemia: alternative etiologies.Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia.Venous Thromboembolism in Children with Cancer and Blood Disorders.Intracardiac shunting and stroke in children: a systematic reviewOxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.Potential role for statins in sickle cell disease.Investigational selectin-targeted therapy of sickle cell disease.Emerging point-of-care technologies for sickle cell disease screening and monitoring.A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.
P2860
Q24193246-730EE3CC-4F2A-4986-BEFD-B744D51DBB6EQ27303155-67D05A4F-7F34-4D93-B8B4-75FAEB1E6EDBQ28383654-3C7B1FB5-FCA7-4571-BCEE-68AB6112D169Q29994630-19B74C27-CAEA-4857-BE65-79FFF7535693Q30429416-E6160ADA-5D1F-4091-A507-E247B037899BQ33722654-56C60EED-62B4-4676-8F7C-F1DDD198E224Q33772082-CDDF0885-A3B2-4993-A24B-BED297149CB8Q34478678-BAC8BB8A-6694-4826-B38A-7683B3B982D5Q34745695-7CDB8065-9818-430B-BF8A-2AEA1DD5BB84Q34924453-F9D03D54-C34A-468C-A269-20EC7CD6504EQ35039996-74C52BE9-FD65-48A1-B5E1-F9B5F6CDFBCBQ35105431-EE774FF7-4E19-4EBD-BBC0-7FCD4B01FDAAQ35227861-1DB2D65A-4852-495C-B9E4-66C6D6DA5C31Q35461421-F73067D4-A634-4616-A89F-76E4FCF1D933Q35590733-7834ACD1-C10A-4BD4-A53E-7D9CB63AD43DQ35754765-ADA2D227-9E5C-42AD-B23E-300FF9D71C56Q35777786-DAFFA5A2-7FAC-43E2-B45E-37FEBF051DBBQ35782720-B5FEB5C5-C25A-4A1C-9FA3-64738A8E2E1DQ36010842-3F31F085-CAB1-4D79-BF91-EFA568C5C06FQ36143295-845812F5-28B8-42EC-A0F3-6CCA25FEE2ABQ36393525-3801A76A-F784-48E1-BB71-8A4F5BED1AA3Q36426649-D40227C8-8E14-4895-AA3F-11C6D39EC62CQ36467377-A800D424-2DA0-4D02-9924-3CCB4D827BAFQ36539098-16ECE428-541D-444F-A626-8A4F8D0C5957Q36596855-93C226F3-60FE-453A-A544-33629836E913Q36649213-F2EDA727-6426-41BE-AF5E-6EC2F09D811DQ36657988-0159EC82-2237-40C6-A030-10B3EB865D08Q36892578-3BE82FB3-53A9-44EC-85B8-8AEE6649215CQ36948107-6B68144C-40D1-48AD-85E8-6FA1AF445108Q37061928-06B593F8-5A9F-4312-8D93-E586210BBBC5Q37340140-FE7AB175-7E76-4B0A-ACA7-0DC0E1E2EDAEQ37406776-A1F4F4F4-4BB7-4972-BD77-F2072CE5E201Q37514497-7C3A9E08-25A0-4752-8B86-7E3BD4079A7DQ37625771-F28BB41B-ACD9-47C5-B6BC-38FB0978B97AQ37826605-C08CF109-1CED-485A-90EA-2656C54B1900Q37872265-48D5AB72-B9CA-4F2E-ACDE-4A7B24CCBB61Q38071047-102B003F-3CED-4B66-83BA-68F8B440EB75Q38253064-45C1E405-DF64-47C9-A201-57EB07C8BC3FQ38804432-8D73E1A5-8A7C-47BC-B7BE-A2B08EE12A8BQ38861043-66A7A598-6192-4B60-B445-8EA93E221F76
P2860
Hypercoagulability in sickle cell disease: a curious paradox.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hypercoagulability in sickle cell disease: a curious paradox.
@ast
Hypercoagulability in sickle cell disease: a curious paradox.
@en
type
label
Hypercoagulability in sickle cell disease: a curious paradox.
@ast
Hypercoagulability in sickle cell disease: a curious paradox.
@en
prefLabel
Hypercoagulability in sickle cell disease: a curious paradox.
@ast
Hypercoagulability in sickle cell disease: a curious paradox.
@en
P1476
Hypercoagulability in sickle cell disease: a curious paradox.
@en
P2093
Eugene P Orringer
Kenneth I Ataga
P304
P356
10.1016/J.AMJMED.2003.07.011
P407
P577
2003-12-01T00:00:00Z